Using an AI trial screening tool to assess language as a barrier for enrollment of underrepresented minorities in cancer clinical trials

被引：0
|
作者：
Corvese, Laura
Weiss, Christina
Huie, Sharon
Zhou, Bin
Deng, Yanhong
Gong, Guannan
Kunz, Pamela L.
Fischbach, Neal A.
机构：
[1] Univ Utrecht, Utrecht, Netherlands
[2] Yale Univ, New Haven, CT USA
[3] Yale Ctr Analyt Sci, New Haven, CT USA
[4] Yale Sch Med, New Haven, CT USA
[5] Yale Univ, Sch Med, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13586
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CLINICAL TRIALS ASSESS A PRECISION-MEDICINE APPROACH TO CANCER SCREENING
    Moutinho, Sofia
    NATURE MEDICINE, 2023, 29 (07) : 1587 - 1590
  • [22] Clinical trials assess a precision-medicine approach to cancer screening
    Sofia Moutinho
    Nature Medicine, 2023, 29 : 1587 - 1590
  • [23] Ineligible, Unaware, or Uninterested? Associations Between Underrepresented Patient Populations and Retention in the Pathway to Cancer Clinical Trial Enrollment
    Caston, Nicole E.
    Lalor, Fallon
    Wall, Jaclyn
    Sussell, Jesse
    Patel, Shilpen
    Williams, Courtney P.
    Azuero, Andres
    Arend, Rebecca
    Liang, Margaret, I
    Rocque, Gabrielle B.
    JCO ONCOLOGY PRACTICE, 2022, 18 (11) : 769 - +
  • [24] Gender minorities in breast cancer - Clinical trials enrollment disparities: Focus on male, transgender and gender diverse patients
    Miglietta, Federica
    Pontolillo, Letizia
    De Angelis, Carmine
    Caputo, Roberta
    Marino, Monica
    Bria, Emilio
    Di Rienzo, Rossana
    Verrazzo, Annarita
    Buonerba, Carlo
    Tortora, Giampaolo
    Di Lorenzo, Giuseppe
    Del Mastro, Lucia
    Giuliano, Mario
    Montemurro, Filippo
    Puglisi, Fabio
    Guarneri, Valentina
    De Laurentiis, Michelino
    Scafuri, Luca
    Arpino, Grazia
    BREAST, 2024, 75
  • [25] Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
    Gillett, Piers
    Mahar, Robert K.
    Tran, Nancy R.
    Rosenthal, Mark
    Ijzerman, Maarten
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [26] Developing and validating a multi-criteria decision analytic tool to assess the value of cancer clinical trials: evaluating cancer clinical trial value
    Piers Gillett
    Robert K Mahar
    Nancy R Tran
    Mark Rosenthal
    Maarten IJzerman
    Cost Effectiveness and Resource Allocation, 21
  • [27] Development of a drug-drug interaction screening tool for oncology clinical trial enrollment.
    Marcath, Lauren A.
    Coe, Taylor D.
    Redman, Bruce G.
    Hertz, Daniel Louis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (30)
  • [28] Predicting therapeutic clinical trial enrollment for underrepresented patients in neuro-oncology using supervised machine learning
    Mehari, Mulki
    Warrier, Gayathri
    Dada, Abraham
    Kabir, Aymen
    Chukwueke, Ugonma Nnenna
    Porter, Alyx B.
    Hervey-Jumper, Shawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Target Trial Emulation: A Design Tool for Cancer Clinical Trials
    Kwee, Sandi A.
    Wong, Linda L.
    Ludema, Christina
    Deng, Chris K.
    Taira, Deborah
    Seto, Todd
    Landsittel, Douglas
    JCO CLINICAL CANCER INFORMATICS, 2023, 7 : e2200140
  • [30] Target Trial Emulation: A Design Tool for Cancer Clinical Trials
    Kwee, Sandi A.
    Wong, Linda L.
    Ludema, Christina
    Deng, Chris K.
    Taira, Deborah
    Seto, Todd
    Landsittel, Douglas
    JCO CLINICAL CANCER INFORMATICS, 2023, 7
12345